FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385308003> ?p ?o ?g. }

• W4385308003 endingPage "1235" @default.
• W4385308003 startingPage "1235" @default.
• W4385308003 abstract "Background: Increasing antibiotic resistance has been reported as an issue in the systemic treatment of periprosthetic joint infection (PJI). Linezolid offers the advantages of high oral bioavailability and little resistance; however, efficacy in the treatment of PJI varies considerably, and studies reporting consistent surgical treatment are scarce. Methods: This is a retrospective, single-center analysis of two-stage revisions performed between 2008 and 2017. We identified 111 patients who met the inclusion criteria. Oral linezolid was given for 28 days following 14 days of intravenous tailored antibiotics in resistant gram-positive PJI. A total of 64% of the patients had methicillin-resistant coagulase-negative staphylococci. The median follow-up was 43 (interquartile range (IQR) 30–57) months. Results: 22% (24/111) of the patients underwent surgery for subsequent infection. The 5-year infection-free survival probability was 77% (95% confidence interval (CI) 69–85). A total of 5% of the patients (6/111) had the same organism at the time of reinfection. The patients with infections caused by other organisms than Coagulase-negative staphylococci tended to have a worse reinfection-free survivorship at five years (70% vs. 81%, p = 0.09). Furthermore, the patients with obesity tended to have reduced reinfection-free survivorship at five years (69% vs. 84%, p = 0.08). Overall, 5% (6/111) of the patients had blood count abnormalities with no treatment discontinuations. Conclusion: Two-stage revision arthroplasty with systemic oral linezolid treatment for resistant gram-positive PJI results in an infection control of 77% at the mid-term." @default.
• W4385308003 created "2023-07-28" @default.
• W4385308003 creator A5037382918 @default.
• W4385308003 creator A5038691076 @default.
• W4385308003 creator A5040858567 @default.
• W4385308003 creator A5048698689 @default.
• W4385308003 creator A5052877005 @default.
• W4385308003 creator A5059842824 @default.
• W4385308003 creator A5077759244 @default.
• W4385308003 creator A5092553432 @default.
• W4385308003 date "2023-07-26" @default.
• W4385308003 modified "2023-09-25" @default.
• W4385308003 title "Two-Stage Revision Arthroplasty for Resistant Gram-Positive Periprosthetic Joint Infections Using an Oral Linezolid-Based Antibiotic Regime" @default.
• W4385308003 cites W1899655172 @default.
• W4385308003 cites W1966218947 @default.
• W4385308003 cites W1977260927 @default.
• W4385308003 cites W1981392377 @default.
• W4385308003 cites W2001280008 @default.
• W4385308003 cites W2001420273 @default.
• W4385308003 cites W2023394860 @default.
• W4385308003 cites W2024582975 @default.
• W4385308003 cites W2025194165 @default.
• W4385308003 cites W2027745339 @default.
• W4385308003 cites W2033319107 @default.
• W4385308003 cites W2070922113 @default.
• W4385308003 cites W2074110800 @default.
• W4385308003 cites W2079575346 @default.
• W4385308003 cites W2116113861 @default.
• W4385308003 cites W2118901469 @default.
• W4385308003 cites W2121238535 @default.
• W4385308003 cites W2129862862 @default.
• W4385308003 cites W2132641140 @default.
• W4385308003 cites W2137275237 @default.
• W4385308003 cites W2138322687 @default.
• W4385308003 cites W2145138274 @default.
• W4385308003 cites W2291618503 @default.
• W4385308003 cites W2331340677 @default.
• W4385308003 cites W2508904015 @default.
• W4385308003 cites W2597423754 @default.
• W4385308003 cites W2607381621 @default.
• W4385308003 cites W2743263966 @default.
• W4385308003 cites W2797131679 @default.
• W4385308003 cites W2806180990 @default.
• W4385308003 cites W2806939891 @default.
• W4385308003 cites W2889115464 @default.
• W4385308003 cites W2898078684 @default.
• W4385308003 cites W2901070409 @default.
• W4385308003 cites W2912155126 @default.
• W4385308003 cites W2924664094 @default.
• W4385308003 cites W2933576828 @default.
• W4385308003 cites W2952527818 @default.
• W4385308003 cites W2966086956 @default.
• W4385308003 cites W3021123353 @default.
• W4385308003 cites W3044720417 @default.
• W4385308003 cites W3164865203 @default.
• W4385308003 cites W4213063740 @default.
• W4385308003 cites W4213197828 @default.
• W4385308003 cites W4252537420 @default.
• W4385308003 doi "https://doi.org/10.3390/antibiotics12081235" @default.
• W4385308003 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37627655" @default.
• W4385308003 hasPublicationYear "2023" @default.
• W4385308003 type Work @default.
• W4385308003 citedByCount "0" @default.
• W4385308003 crossrefType "journal-article" @default.
• W4385308003 hasAuthorship W4385308003A5037382918 @default.
• W4385308003 hasAuthorship W4385308003A5038691076 @default.
• W4385308003 hasAuthorship W4385308003A5040858567 @default.
• W4385308003 hasAuthorship W4385308003A5048698689 @default.
• W4385308003 hasAuthorship W4385308003A5052877005 @default.
• W4385308003 hasAuthorship W4385308003A5059842824 @default.
• W4385308003 hasAuthorship W4385308003A5077759244 @default.
• W4385308003 hasAuthorship W4385308003A5092553432 @default.
• W4385308003 hasBestOaLocation W43853080031 @default.
• W4385308003 hasConcept C119060515 @default.
• W4385308003 hasConcept C126322002 @default.
• W4385308003 hasConcept C141071460 @default.
• W4385308003 hasConcept C167135981 @default.
• W4385308003 hasConcept C2778120723 @default.
• W4385308003 hasConcept C2778336525 @default.
• W4385308003 hasConcept C2778980435 @default.
• W4385308003 hasConcept C2779489039 @default.
• W4385308003 hasConcept C2781414143 @default.
• W4385308003 hasConcept C3020326648 @default.
• W4385308003 hasConcept C44249647 @default.
• W4385308003 hasConcept C501593827 @default.
• W4385308003 hasConcept C523546767 @default.
• W4385308003 hasConcept C54355233 @default.
• W4385308003 hasConcept C71924100 @default.
• W4385308003 hasConcept C86803240 @default.
• W4385308003 hasConcept C89423630 @default.
• W4385308003 hasConceptScore W4385308003C119060515 @default.
• W4385308003 hasConceptScore W4385308003C126322002 @default.
• W4385308003 hasConceptScore W4385308003C141071460 @default.
• W4385308003 hasConceptScore W4385308003C167135981 @default.
• W4385308003 hasConceptScore W4385308003C2778120723 @default.
• W4385308003 hasConceptScore W4385308003C2778336525 @default.
• W4385308003 hasConceptScore W4385308003C2778980435 @default.
• W4385308003 hasConceptScore W4385308003C2779489039 @default.

• next